Branding and Immune Response - Clinical Research Informer

Herd immunity won’t stop the outbreak: 3 Dangerous Covid-19 Myths

Find Me Cure

APRIL 23, 2020

Vandalizing cell towers is not going to get rid of this new virus in the corona family and avoiding certain brands of beer is not a good prevention strategy. . Thus, herd immunity wouldn’t work in this scenario. On the other hand, not suppressing the immune system can lead to the body’s own immune response destroying it. .

Immune Response

Immune Response Antibody Scientist Development

Is Probiotic Soda Actually Healthy and Which Companies Produce It?

XTalks

JULY 21, 2022

Now, more and more probiotic soda brands are popping up, each claiming to support gut health and digestion. They can also help your body maintain a healthy community of microorganisms, produce substances that have desirable effects and influence your body’s immune response. But are probiotic sodas actually healthy? .

Containment

Containment Branding Bacteria Immune Response

Cell-Mediated Therapies for Infectious Disease Summit

pharmaphorum

MARCH 23, 2021

In the fight against emerging coronavirus variants and spike mutations, the need for long-lasting immunity is greater than ever. This is why the time is now to look beyond antibodies and capitalize on the long-term immune response of T cell therapies. Check out the brand-new event guide here.

Immune Response

Immune Response Vaccination Vaccine Branding

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

For Maximum Effectiveness, De-Stress and Get Healthy Before Your COVID Shot

The Pharma Data

JANUARY 22, 2021

But while you wait your turn, there are some steps you can take to give the vaccine — whichever brand you get — a boost when it’s available to you. An Ohio State University review of 49 vaccine studies dating back 30 years examined how stress, depression and healthy behaviors, such as exercise, can affect immune response to a vaccine.

Immune Response

Immune Response Vaccination Vaccine Antibody

FDA clears Dupixent as first drug for rare skin disorder

pharmaphorum

SEPTEMBER 29, 2022

The disorder – driven by type 2 inflammation characterised by an antibody-based immune response – causes hard lumps or nodules to form on the skin that are so itchy they can lead patients to scratch themselves to the point of bleeding or pain.

Drugs

Drugs Immune Response Allergies Sales

BioSpace Global Roundup: Companies Slash Prices to Meet China’s Health Coverage

The Pharma Data

DECEMBER 30, 2020

The Phase I/II study results, together with recently generated preclinical data, indicate that ARCT-021 leads to a potent immune response to SARS-CoV-2, and demonstrates a differentiated biological profile whereby the immune response increases in the weeks following vaccination, the company said.

Genome

Genome Genomics Immune Response Vaccination

FDA clears Pfizer’s Prevnar 20 for adults, as Merck rival nears decision

pharmaphorum

JUNE 9, 2021

V114 covers 15 serotypes, so the jury is out on whether it will be a big challenger to Pfizer’s well-established brand now that Prevnar 20 is becoming available. In two phase 3 trials in adults reported last year, V114 stimulated immune responses to all serotypes in the shot.

Vaccination

Vaccination Vaccine Immune Response Regulation

Positive results from the first study of high-dose influenza vaccine with a COVID-19 mRNA booster support co-administration recommendations

The Pharma Data

OCTOBER 6, 2021

It is also licensed under the brand name Efluelda ® in Europe where it is indicated for adults aged 60 and older. The study assesses the safety profile and immune response when COVID-19 mRNA investigational booster vaccine (100 mcg dose) and high-dose quadrivalent influenza vaccine are administered simultaneously.

Vaccination

Vaccination Vaccine Licensing Licensing

Digital innovation drives vaccine development

pharmaphorum

JANUARY 31, 2022

As Shanaya says, some of the biggest developments have involved mRNA vaccines, “a completely different way to stimulate an immune response.”. Telesofia Medical’s entry will automate the process of creating branded and personalized educational videos for healthcare patients. Innovation at Pfizer. Generating awareness.

Vaccination

Vaccination Vaccine Development Marketing

Keeping tabs on Covid-19: UK firm tests oral delivery of Covid-19 vaccine and Novavax aims to distribute 51 million vaccines to Australia

The Pharma Data

JANUARY 22, 2021

Novavax’s vaccine is a recombinant protein vaccine adjuvanted with Novavax’s nanoparticle technology, Matrix-M, which enhances immune response in recipients. Scientists have been aiming to complete late-stage clinical studies to demonstrate the efficacy, safety and immunogenicity of NVX-CoV2373 for the prevention of Covid-19.

Vaccination

Vaccination Vaccine Protein Immune Response

U.S. FDA APPROVES TICOVAC™, PFIZER’S TICK-BORNE ENCEPHALITIS (TBE) VACCINE

The Pharma Data

AUGUST 15, 2021

About TICOVAC (Tick-borne encephalitis vaccine) Pfizer’s TBE vaccine, marketed under the brand names FSME-Immun ® and TicoVac in Europe, and TICOVAC in the U.S., More than 45 years of experience with the Pfizer TBE vaccine exist outside the U.S., and more than 170 million doses of the vaccine have been distributed since 1976.

FDA Approval

FDA Approval Vaccination Vaccine Containment

Thrombocytopenia Drugs Market: What Newer Agents Are Expected To Enter The Market?

Delveinsight

JANUARY 22, 2021

Albeit, in the past two decades, a lot has been learnt and understood about the etiology of the pathogenesis of Drug-Induced Thrombocytopenia, the knowledge of the molecular nature of the drugs, immune-response to the drugs and the production of antibodies in the body is far from complete.

Marketing

Marketing Drugs Antibody Compliance

SELLAS Announces Promising Initial Clinical Data for Galinpepimut-S (GPS) in Combination with Checkpoint Inhibitors in Two Solid Tumor Indications

The Pharma Data

DECEMBER 20, 2020

The primary endpoints of the study include safety and overall response rate, while secondary endpoints include progression-free survival, overall survival and immune response correlates. The manufacturer of this brand is not affiliated with and does not endorse SELLAS or its products. Kenilworth, N.J., Kenilworth, N.J.,

Life Science

Life Science Immune Response Trials Clinical Trials

Electromedical Technologies Produces $4.2 Million in Device Inventory to Meet Demand

The Pharma Data

NOVEMBER 18, 2020

We have a way to help thousands of people to live a better quality of life, pain free and addiction free and at the same time provide a real income opportunity for anyone who wishes to join our brand ambassador team.” ( [link] ).

Production

Production Containment Immune Response Regulation

Emotional empathy is driving brand equity

pharmaphorum

AUGUST 13, 2020

How the COVID-19 pandemic is forging pharmaceutical brands into better shape. Day by day it becomes clearer that some brands are coming through the pandemic in better shape than ever. These are the brands that have clearly demonstrated emotional intelligence, that have shown emotional empathy to their target audience.

Branding

Branding Vaccine Vaccination Filler

Top 5 Most Promising FDA New Drug Approvals Expected in the Second Half of 2024

XTalks

MAY 2, 2024

Among these are Madrigal Pharmaceuticals’ resmetirom (branded Rezdiffra) , which secured FDA approval in March for the treatment of nonalcoholic steatohepatitis (NASH) and sotatercept (commercial name Winrevair) for pulmonary hypertension (PAH). Since January, the FDA has already signed off on more than a dozen novel drugs.

Drugs

Drugs FDA Approval Vaccination Vaccine

Clinical Catch-Up: December 14-18 | BioSpace

The Pharma Data

DECEMBER 20, 2020

Pfizer and BioNTech announced additional data on neutralizing antibody and T-cell responses from their Phase I/II trial of their COVID-19 vaccine conducted in Germany. The drug, under the brand name Rybelsus, is approved as an adjunct to diet and exercise for adults with type 2 diabetes.

Trials

Trials Gene Therapy Vaccination Vaccine

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But Pharmaceutical Marketers Can Do Much to Address the Problem

Pharma Marketing Network

DECEMBER 21, 2020

These are critical, both for educational reasons (they can be effective in bringing abstract or complex concepts to life) and promotional purposes (to create a distinct brand identity in the crowded landscape). Scientific visualization and animation. Creation of “snackable content.”

Genetics

Genetics Medicine Gene Therapy Marketing

Systemic Lupus Erythematosus Treatment Market: How the Leading Companies are Countering the Rising Prevalence?

Delveinsight

SEPTEMBER 8, 2021

It is sold under the brand name Plaquenil and is available only by prescription. Lupuzo is a medication that specifically modulates the immune system of lupus patients by changing the behaviour of some of the key cells involved in the disease’s pathogenesis. It is also available as a generic medicine.

Marketing

Marketing Sales FDA Approval Antibody

Advisory Committee on Immunization Practices Recommends Pfizer’s PREVNAR 20® for Adults Previously Vaccinated with PREVNAR 13®

Pfizer

OCTOBER 20, 2022

On February 15, 2022, Pfizer announced the European Medicines Agency (EMA) approved the company’s 20-valent pneumococcal conjugate vaccine, which is marketed in the European Union (EU) under the brand name APEXXNAR. .

Vaccination

Vaccination Vaccine Containment Immune Response

Transgene Announces Detailed Results From Clinical Study of TG4001 in Combination With Avelumab in Advanced HPV-positive Cancers

The Pharma Data

OCTOBER 26, 2020

In addition, the observed median PFS shows that the regimen can induce a sustained and durable response, which is also shown consistently by the induction of a specific immune response. I believe this combination regimen has the opportunity to provide real hope for patients with HPV-16 related cancers.”.

Vaccination

Vaccination Vaccine Trials Containment

Sanofi continued its growth trajectory. Strong increase in Q1 2021 business EPS(1) at CER

The Pharma Data

APRIL 27, 2021

due to COVID related stocking in Q1 2020 and low demand for cough and cold brands in Europe. Dupixent ® total prescriptions (TRx) increased 51% ( year-over-year ) and new-to-brand prescriptions (NBRx) grew 16% despite fewer in-person physician visits which remain below the pre-COVID level. CHC decreased 7.3% In the U.S.,

Sales

Sales Vaccination Vaccine Medicine

Sanofi delivered close to double-digit Q4 2020

The Pharma Data

FEBRUARY 8, 2021

due to decreased sales of Cough & Cold related portfolio in Europe partially offset by Digestive Health brands. Dupixent ® total prescriptions (TRx) increased 65% ( year-over-year ) and new-to-brand prescriptions (NBRx) grew 18% despite fewer in-person physician visits which remain below the pre-COVID level. CHC down 3.0%

Sales

Sales Vaccination Vaccine Production

Sanofi delivered close to double-digit Q4 2020 business EPS(1) growth at CER

The Pharma Data

FEBRUARY 4, 2021

due to decreased sales of Cough & Cold related portfolio in Europe partially offset by Digestive Health brands. Dupixent ® total prescriptions (TRx) increased 65% ( year-over-year ) and new-to-brand prescriptions (NBRx) grew 18% despite fewer in-person physician visits which remain below the pre-COVID level. CHC down 3.0%

Sales

Sales Vaccination Vaccine Production

COVID-19 Pandemic Coverage

XTalks

SEPTEMBER 14, 2020

It was recently reported that the addition of an adjuvant to their vaccine led to enhanced immune responses that exceeded responses in convalescent serum from symptomatic COVID-19 patients. Novavax has also tested its recombinant SARS-CoV-2 nanoparticle adjuvanted vaccine in a Phase I/II trial.

Vaccine

Vaccine Vaccination Antibody Life Science

Clinical Research Informer

Herd immunity won’t stop the outbreak: 3 Dangerous Covid-19 Myths

Is Probiotic Soda Actually Healthy and Which Companies Produce It?

Webinars

Trending Sources

Cell-Mediated Therapies for Infectious Disease Summit

Webinars

For Maximum Effectiveness, De-Stress and Get Healthy Before Your COVID Shot

FDA clears Dupixent as first drug for rare skin disorder

BioSpace Global Roundup: Companies Slash Prices to Meet China’s Health Coverage

FDA clears Pfizer’s Prevnar 20 for adults, as Merck rival nears decision

Positive results from the first study of high-dose influenza vaccine with a COVID-19 mRNA booster support co-administration recommendations

Digital innovation drives vaccine development

Keeping tabs on Covid-19: UK firm tests oral delivery of Covid-19 vaccine and Novavax aims to distribute 51 million vaccines to Australia

U.S. FDA APPROVES TICOVAC™, PFIZER’S TICK-BORNE ENCEPHALITIS (TBE) VACCINE

Thrombocytopenia Drugs Market: What Newer Agents Are Expected To Enter The Market?

SELLAS Announces Promising Initial Clinical Data for Galinpepimut-S (GPS) in Combination with Checkpoint Inhibitors in Two Solid Tumor Indications

Electromedical Technologies Produces $4.2 Million in Device Inventory to Meet Demand

Emotional empathy is driving brand equity

Top 5 Most Promising FDA New Drug Approvals Expected in the Second Half of 2024

Clinical Catch-Up: December 14-18 | BioSpace

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But Pharmaceutical Marketers Can Do Much to Address the Problem

Systemic Lupus Erythematosus Treatment Market: How the Leading Companies are Countering the Rising Prevalence?

Advisory Committee on Immunization Practices Recommends Pfizer’s PREVNAR 20® for Adults Previously Vaccinated with PREVNAR 13®

Transgene Announces Detailed Results From Clinical Study of TG4001 in Combination With Avelumab in Advanced HPV-positive Cancers

Sanofi continued its growth trajectory. Strong increase in Q1 2021 business EPS(1) at CER

Sanofi delivered close to double-digit Q4 2020

Sanofi delivered close to double-digit Q4 2020 business EPS(1) growth at CER

COVID-19 Pandemic Coverage

Stay Connected